CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 2030978888 support@capital.com

交易 Quince Therapeuticks Inc - QNCX CFD

1.4587
7.35%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.0226
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.024068%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 1.3588
开盘价* 1.3787
1 年变化* -77.32%
日范围* 1.3688 - 1.4687
52 周范围 0.54-6.80
平均交易量（10 天） 5.74M
平均交易量（3 个月) 46.87M
市值 49.70M
市盈率 -100.00K
流通股 36.28M
收入 N/A
EPS -1.61
股息（收益率 %） N/A
贝塔 1.21
下一个财报发布日期 N/A

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 24, 2023 1.4587 0.0600 4.29% 1.3987 1.4787 1.3488
Mar 23, 2023 1.3588 -0.0899 -6.21% 1.4487 1.4687 1.3488
Mar 22, 2023 1.4187 0.0200 1.43% 1.3987 1.4687 1.3688
Mar 21, 2023 1.4187 0.0000 0.00% 1.4187 1.5186 1.3388
Mar 20, 2023 0.8196 0.0004 0.05% 0.8192 0.8360 0.7892
Mar 17, 2023 0.8188 -0.0171 -2.05% 0.8359 0.8359 0.7848
Mar 16, 2023 0.8193 -0.0066 -0.80% 0.8259 0.8557 0.7919
Mar 15, 2023 0.8410 -0.0382 -4.34% 0.8792 0.8792 0.8155
Mar 14, 2023 0.8716 -0.0339 -3.74% 0.9055 0.9155 0.8691
Mar 13, 2023 0.8791 -0.0663 -7.01% 0.9454 0.9454 0.8656
Mar 10, 2023 0.9237 -0.0326 -3.41% 0.9563 0.9752 0.9237
Mar 9, 2023 0.9743 -0.0247 -2.47% 0.9990 1.0490 0.9643
Mar 8, 2023 0.9832 0.0080 0.82% 0.9752 0.9950 0.9393
Mar 7, 2023 0.9591 0.0079 0.83% 0.9512 0.9784 0.9491
Mar 6, 2023 0.9667 0.0023 0.24% 0.9644 0.9868 0.9433
Mar 3, 2023 0.9738 -0.0114 -1.16% 0.9852 0.9991 0.9695
Mar 2, 2023 0.9858 0.0404 4.27% 0.9454 0.9988 0.9392
Mar 1, 2023 0.9482 0.0228 2.46% 0.9254 0.9800 0.9118
Feb 28, 2023 0.9221 0.0066 0.72% 0.9155 0.9454 0.8908
Feb 27, 2023 0.9127 -0.0376 -3.96% 0.9503 0.9503 0.8745

Quince Therapeuticks Inc Events

時間（協調世界時） (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 0 0 0 0 0
总营业费用 90.318 78.893 39.168 12.119 10.37
销售/一般/行政费用，总计 29.523 17.586 8.954 2.034 1.271
研究与开发 60.795 61.307 30.214 10.085 9.099
营业收入 -90.318 -78.893 -39.168 -12.119 -10.37
利息收入（费用），非经营净值 0.62 2.044 2.188 -0.357 -1.865
税前净收入 -89.945 -76.849 -36.98 -12.476 -12.235
税后净收入 -89.945 -76.849 -36.98 -12.476 -12.235
未计算非常项目前的净收益 -89.945 -76.849 -36.98 -12.476 -12.235
非常规项目总计 0
净收入 -89.945 -76.849 -36.98 -12.476 -12.235
普通股股东可获收益 (不含非经常性项目) -89.945 -76.849 -36.98 -12.476 -12.235
普通股股东可获收益 (含非經常性項目) -89.945 -76.849 -36.98 -12.476 -12.235
摊薄净收入 -89.945 -76.849 -36.98 -12.476 -12.235
摊薄后加权平均股 29.7185 29.1762 19.0319 26.0133 26.0133
扣除特别项目的每股摊薄盈利 -3.02657 -2.63396 -1.94305 -0.4796 -0.47034
Dividends per Share - Common Stock Primary Issue 0 0
每股正常摊薄盈利 -3.02657 -2.63396 -1.94305 -0.4796 -0.47034
其他，净值 -0.247
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 0 0 0 0 0
总营业费用 21.863 23.544 21.677 21.783 23.313
销售/一般/行政费用，总计 9.106 8.331 7.639 7.064 6.489
研究与开发 12.757 15.213 14.038 14.719 16.824
营业收入 -21.863 -23.544 -21.677 -21.783 -23.313
利息收入（费用），非经营净值 0.072 0.105 0.128 0.16 0.227
税前净收入 -21.641 -23.399 -21.706 -21.754 -23.086
税后净收入 -21.641 -23.399 -21.706 -21.754 -23.086
未计算非常项目前的净收益 -21.641 -23.399 -21.706 -21.754 -23.086
净收入 -21.641 -23.399 -21.706 -21.754 -23.086
普通股股东可获收益 (不含非经常性项目) -21.641 -23.399 -21.706 -21.754 -23.086
普通股股东可获收益 (含非經常性項目) -21.641 -23.399 -21.706 -21.754 -23.086
摊薄净收入 -21.641 -23.399 -21.706 -21.754 -23.086
摊薄后加权平均股 30.1345 29.962 29.7674 29.5874 29.5549
扣除特别项目的每股摊薄盈利 -0.71815 -0.78095 -0.72919 -0.73525 -0.78112
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.71815 -0.78095 -0.72919 -0.73525 -0.78112
其他，净值 0.15 0.04 -0.157 -0.131
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 111.673 137.862 106.056 72.584 7.537
现金和短期投资 106.802 133.82 99.864 71.716 7.343
Cash 40.27 35.69 4.074 11.259 7.343
现金等价物 15.954 16.151 46.155 11.815 0
短期投资 50.578 81.979 49.635 48.642 0
Prepaid Expenses 3.376 3.348 5.504 0.766 0.141
Other Current Assets, Total 1.495 0.694 0.688 0.102 0.053
Total Assets 133.228 189.466 124.37 72.877 7.718
Property/Plant/Equipment, Total - Net 1.428 1.101 1.334 0.283 0.122
Property/Plant/Equipment, Total - Gross 2.387 1.716 1.617 0.378 0.166
Accumulated Depreciation, Total -0.959 -0.615 -0.283 -0.095 -0.044
Other Long Term Assets, Total 0.194 0.039 0.217 0.01 0.059
Total Current Liabilities 14.222 16.996 8.892 1.457 1.763
Accounts Payable 4.911 3.555 3.075 0.495 0.517
Accrued Expenses 9.311 13.441 5.817 0.962 1.246
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 14.642 17.204 8.892 1.457 10.82
Total Long Term Debt 0 0 0 0 7.171
Long Term Debt 0 7.171
Other Liabilities, Total 0.42 0.208 0 1.886
Total Equity 118.586 172.262 115.478 71.42 -3.102
Redeemable Preferred Stock 0 104.046 17.178
Common Stock 0.03 0.029 0.027 0.009 0.009
Additional Paid-In Capital 355.234 318.574 185.196 0.239 0.06
Retained Earnings (Accumulated Deficit) -236.599 -146.654 -69.805 -32.825 -20.349
Other Equity, Total -0.079 0.313 0.06 -0.049 0
Total Liabilities & Shareholders’ Equity 133.228 189.466 124.37 72.877 7.718
Total Common Shares Outstanding 30.0744 29.5432 26.8694 26.0133 26.0133
Long Term Investments 19.933 50.464 16.763
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 96.353 111.673 119.427 135.843 149.885
现金和短期投资 91.524 106.802 114.412 129.95 147.035
Cash 27.403 40.27 8.357 5.744 24.569
现金等价物 32.361 15.954 36.6 47.049 38.246
短期投资 31.76 50.578 69.455 77.157 84.22
Prepaid Expenses 2.784 3.376 4.52 5.455 2.293
Other Current Assets, Total 2.045 1.495 0.495 0.438 0.557
Total Assets 116.13 133.228 147.416 161.39 174.522
Property/Plant/Equipment, Total - Net 0.573 1.428 1.655 1.886 0.878
Property/Plant/Equipment, Total - Gross 1.569 2.387 2.53 2.674 1.579
Accumulated Depreciation, Total -0.996 -0.959 -0.875 -0.788 -0.701
Long Term Investments 19.175 19.933 26.141 23.516 23.72
Other Long Term Assets, Total 0.029 0.194 0.193 0.145 0.039
Total Current Liabilities 9.71 14.222 14.154 18.537 17.867
Accounts Payable 3.731 4.911 2.88 7.193 2.845
Accrued Expenses 5.979 9.311 11.274 11.344 15.022
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 9.75 14.642 14.764 19.31 18.038
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.04 0.42 0.61 0.773 0.171
Total Equity 106.38 118.586 132.652 142.08 156.484
Common Stock 0.03 0.03 0.03 0.03 0.029
Additional Paid-In Capital 365.096 355.234 345.751 333.427 326.006
Retained Earnings (Accumulated Deficit) -258.24 -236.599 -213.2 -191.494 -169.74
Other Equity, Total -0.506 -0.079 0.071 0.117 0.189
Total Liabilities & Shareholders’ Equity 116.13 133.228 147.416 161.39 174.522
Total Common Shares Outstanding 30.1496 30.0744 29.8673 29.6558 29.5759
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -89.945 -76.849 -36.98 -12.476 -12.235
经营活动产生的现金 -62.932 -50.818 -33.277 -11.695 -9.827
经营活动产生的现金 0.344 0.332 0.188 0.051 0.045
非现金物品 30.93 15.472 1.611 1.12 1.903
已付现金利息 0.001 0.001
营运资金的变化 -4.261 10.227 1.904 -0.39 0.46
投资活动产生的现金 58.952 -52.431 -17.747 -46.754 -0.077
资本支出 -0.18 -0.052 -0.055 -0.212 -0.077
其他投资现金流量项目，总计 59.132 -52.379 -17.692 -46.542 0
融资活动产生的现金 6.808 118.876 77.366 75.928 7.75
股票的发行（报废），净额 6.808 118.91 77.925 75.678 0
债务的发行（退还），净额 0 -0.034 -0.559 0.25 7.75
现金净变化 2.883 15.627 26.342 17.479 -2.154
外汇效应 0.055
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -21.641 -89.945 -66.546 -44.84 -23.086
Cash From Operating Activities -16.091 -62.932 -48.514 -31.172 -13.61
Cash From Operating Activities 0.038 0.344 0.26 0.173 0.086
Non-Cash Items 9.375 30.93 22.238 14.371 7.285
Changes in Working Capital -3.863 -4.261 -4.466 -0.876 2.105
Cash From Investing Activities 13.413 58.952 38.033 37.267 31.643
Capital Expenditures -0.005 -0.18 -0.136 -0.136 -0.037
Other Investing Cash Flow Items, Total 13.418 59.132 38.169 37.403 31.68
Cash From Financing Activities 0.622 6.808 5.818 1.113 0.441
Issuance (Retirement) of Stock, Net 0.622 6.808 5.818 1.113 0.441
Net Change in Cash -2.16 2.883 -4.634 7.208 18.474
Issuance (Retirement) of Debt, Net 0 0 0
Foreign Exchange Effects -0.104 0.055 0.029
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Lamond (David A.) Individual Investor 10.1543 3683658 1634720 2022-01-31
Dominy (Stephen S) Individual Investor 3.9631 1437674 763 2022-01-31
Lynch (Casey C) Individual Investor 3.2544 1180580 -120000 2022-01-31
EPIQ Capital Group, LLC Investment Advisor 2.9115 1056191 -1000478 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 2.4701 896084 -61145 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.3524 853391 -18615 2022-12-31 LOW
Pfizer Inc Corporation 1.6539 600000 -1456377 2021-12-31 MED
Millennium Management LLC Hedge Fund 1.6424 595801 137810 2022-12-31 HIGH
Low (Philip S) Individual Investor 1.2551 455309 455309 2022-05-19
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9169 332627 -165208 2022-12-31 LOW
Thye (Dirk) Individual Investor 0.7744 280911 280911 2022-05-19
Lowe (Christopher P) Individual Investor 0.7305 265000 175000 2022-03-03 LOW
Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 0.6904 250458 -264583 2022-12-31 HIGH
Smith (Karen L) Individual Investor 0.5367 194690 194690 2022-05-19 LOW
Alphabet, Inc. Venture Capital 0.5213 189122 0 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.4248 154100 -180125 2022-12-31 HIGH
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.4239 153788 0 2022-12-31 MED
Holsinger (Leslie) Individual Investor 0.3985 144580 -10920 2022-06-06
Detke (Michael J) Individual Investor 0.3859 140000 140000 2022-03-03
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3779 137086 -9128 2022-12-31 LOW

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

Cortexyme Inc. Company profile

关于 Cortexyme Inc.

Cortexyme, Inc.是一家处于临床阶段的生物制药公司，专注于提供治疗阿尔茨海默氏症和其他退行性疾病的疾病修饰疗法。 公司提供的3CLpro抑制剂COR803产品，是治疗冠状病毒感染的先导化合物。 公司的产品管道包括用于治疗中枢神经系统（CNS）疾病的候选药物，包括阿尔茨海默病；用于治疗肿瘤的应用，包括预防口腔鳞状细胞癌，以及用于治疗服务不足的慢性疾病，如牙周炎。 公司的COR388用于治疗阿尔茨海默氏病和帕金森氏病。 公司的COR588正处于第一阶段的临床试验，目标是用于治疗牙周病和其他与牙龈炎有关的适应症。 公司还在开发COR588，这是一种第二代脑穿透性赖氨酸牙龈蛋白酶抑制剂。

Industry: Biotechnology & Medical Research (NEC)

269 East Grand Ave
94080

收入报表

  • Annual
  • Quarterly

人们也观看

BTC/USD

27,653.30 Price
-0.010% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

Gold

1,978.85 Price
-0.760% 1D Chg, %
多头隔夜费 -0.0179%
空头隔夜费 0.0097%
隔夜费时间 21:00 (UTC)
价差 0.30

XRP/USD

0.45 Price
+5.510% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00362

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多头隔夜费 -0.0194%
空头隔夜费 -0.0025%
隔夜费时间 21:00 (UTC)
价差 0.03

还在找一位您可以信任的经纪商吗？

加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易